NCT03952845View on ClinicalTrials.gov

Intranasal Capsaicinoid Spray

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

July 1, 2030

Study Completion Date

December 1, 2030

Conditions
ToleranceCapsaicinRhinitis
Interventions
OTHER

Capsaicinoid

This is a tolerability study on doses lower than previously published for the use of intranasal capsaicinoid in the treatment of rhinitis

Trial Locations (1)

B3H 2Y9

Queen Elizabeth II Health Science Center, Halifax

All Listed Sponsors
lead

Nova Scotia Health Authority

OTHER

NCT03952845 - Intranasal Capsaicinoid Spray | Biotech Hunter | Biotech Hunter